Significance of WT1 and multiparameter flow cytometry assessment in patients with chronic myelomonocytic leukemia receiving allogeneic hematopoietic stem cell transplantation.

Xinan PanMeng-Ge GaoYuqian SunYang ZhouKe WangYu WangLanping XuXiaohui ZhangXiaojun HuangXiao-Jun Huang

Published in: International journal of laboratory hematology (2022)

Both FCM and WT1 after HSCT were identified as important predictors of recurrence of CMML following transplantation and may be useful in guiding interventions against disease relapse.

Keyphrases

flow cytometry
allogeneic hematopoietic stem cell transplantation
acute myeloid leukemia
free survival
acute lymphoblastic leukemia
physical activity
bone marrow
cell therapy
stem cells